Corporate report
UKHSA 2025 pipeline snapshot
Published 29 April 2025
© Crown copyright 2025
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/ukhsa-2025-pipeline-snapshot/ukhsa-2025-pipeline-snapshot
Digital
| Title | Estimated Procurement Start date | Estimated Contract Start date | Estimated Contract Value | Estimated Contract Length | Planned Procurement Route |
|---|---|---|---|---|---|
| (IACS) Cyber Security Management System implementation | 1-Apr-25 | 30-Apr-25 | £2m | 2 to 5 years | PCR Framework |
| Microsoft Azure Cloud Platform Tender | 27-Mar-25 | 1-Apr-25 | £6m | 1 to 2 years | PCR Framework – Direct Award |
Diagnostics and Labs
| Title | Estimated Procurement Start date | Estimated Contract Start date | Estimated Contract Value | Estimated Contract Length | Planned Procurement Route |
|---|---|---|---|---|---|
| PCR Viral Load Detection and Immunocompromised Assays | 7 April 2025 | 26 May 2025 | £2.94m | 2 to 5 years | PCR Framework |
| Culture Media in UKHSA Regional and Reference laboratories | 27 March 2025 | 1 April 2025 | £6m | 1 to 2 years | PCR Framework – Direct Award |
Estates
| Title | Estimated Procurement Start date | Estimated Contract Start date | Estimated Contract Value | Estimated Contract Length | Planned Procurement Route |
|---|---|---|---|---|---|
| Furniture and Removals | 28 June 2025 | 20 Oct 2025 | £2m | 2 to 5 years | PCR Framework |
| Supply of Electricity | 1 January 2027 | 21 Feb 2027 | £10m | 2 to 5 years | PA 23 Framework |
| Porton Main Plenum Replacement | 1 June 2025 | 1 Oct 2025 | £30m | 2 to 5 years | PA23 Open Procedure |
| Porton – Hard Facilities Management | 20 September 2025 | 4 Jan 2027 | £35m | 5+ years | PCR Framework |
| Corporate Supply of Contingent Labour | 1 April 2025 | 1 June 2025 | £18m | 2 to 5 years | PCR Framework – Direct Award |
Corporate
| Title | Estimated Procurement Start date | Estimated Contract Start date | Estimated Contract Value | Estimated Contract Length | Planned Procurement Route |
|---|---|---|---|---|---|
| Single Service Centre (SSC) | 22 September 2025 | 18 November 2026 | £253.6m | 2 to 5 years | PA23 Open Procedure |
Science
| Title | Estimated Procurement Start date | Estimated Contract Start date | Estimated Contract Value | Estimated Contract Length | Planned Procurement Route |
|---|---|---|---|---|---|
| UKHSA Diagnostics and Research Open Framework | 18 August 2025 | 14 November 2025 | £5b | 5+ years | PA23 Open or Competitive Flexible Procedure – New Framework |
Vaccines
| Title | Estimated Procurement Start date | Estimated Contract Start date | Estimated Contract Length | Planned Procurement Route |
|---|---|---|---|---|
| Centralised Adult Flu Dynamic Market | 10 October 2025 | 07 November 2025 | 5+ years | PA23 Establishing a Dynamic Market |
| Centralised Adult Flu Procurement under Dynamic Market | 05 August 2026 | 30 November 2026 | 1 to 2 Years | PA23 Competitive award by reference to a Dynamic Market |
| Storage & Distribution Medicines, Vaccines & Associated Medical Products | 1 April 2026 | 30 September 2026 | 5+ years | PA23 Open Procedure |
| Herpes zoster vaccine, inactivated (2027) | 1 February 2026 | 1 April 2027 | 1 to 2 Years | TBC |
| Live attenuated intranasal influenza vaccine 2026 | 1 September 2025 | 1 August 2026 | 2 to 5 years | PA23 Open Procedure |
| Meningitis B vaccine (2026) | 1 January 2026 | 1 August 2026 | 1 to 2 Years | TBC |
| Pneumococcal conjugate vaccine for children (2026)) | 17 November 2025 | 31 July 2026 | 2 to 5 years | PA23 Open Procedure |
| RSV immunisation products - Adults (2028) | 1 December 2025 | 30 June 2026 | 2 to 5 years | PA23 Open Procedure |
| Meningococcal ACWY vaccine (2027) | 1 February 2026 | 1 August 2027 | 2 to 5 years | PA23 Open or Competitive Flexible Procedure – New Framework |
| RSV immunisation products - Infants (2028) | 1 December 2026 | 30 June 2028 | 2 to 5 years | PA23 Open Procedure |
| Inactivated vaccine for childrens flu programme (08-2025) | 1 August 2025 | 1 August 2025 | 1 to 2 Years | PA23 Open Procedure |
| BCG (tuberculosis) vaccine (2027) | 1 April 2026 | 1 April 2027 | 2 to 5 years | PA23 Open Procedure |
| PPER response replacement of DPS for procurement of Antibiotics and IV Fluids | 20 April 2025 | 1 May 2026 | 5+ years | PA23 Establishing a Dynamic Market |
| Pandemic preparedness replacement Antiviral medicines contracts | 6 May 2025 | 1 April 2026 | 2 to 5 years | PA23 Competitive Flexible Procedure |